Smoking status is a risk factor for recurrence after transurethral resection of non-muscle-invasive bladder cancer

European Urology

Volumn 60, Issue 4, 2011, Pages 713-720

  Lammers, Rianne J M ^a   Witjes, Wim P J ^a,b   Hendricksen, Kees ^a   Caris, Christien T M ^b   Janzing Pastors, Maria H C ^b   Witjes, J Alfred ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b CuraTrial SMO and Research   (Netherlands)

Author keywords

Non muscle invasive bladder cancer; Recurrence; Smoking; Survival

Indexed keywords

EPIRUBICIN;

AGED; ARTICLE; BLADDER CANCER; CANCER GROWTH; CANCER RECURRENCE; CANCER SURVIVAL; CIGARETTE SMOKING; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; NON MUSCLE INVASIVE BLADDER CANCER; PASSIVE SMOKING; PHASE 3 CLINICAL TRIAL; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; PROSPECTIVE STUDY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RECURRENCE FREE SURVIVAL; RISK FACTOR; TRANSURETHRAL RESECTION; UNIVARIATE ANALYSIS;

AGED; ANTIBIOTICS, ANTINEOPLASTIC; CARCINOMA; COMBINED MODALITY THERAPY; EPIRUBICIN; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; SMOKING; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS; UROLOGIC SURGICAL PROCEDURES;

EID: 80052263108     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2011.07.010     Document Type: Article

References (27)

1. X. Wu, M.M. Ros, J. Gu, and L. Kiemeney Epidemiology and genetic susceptibility to bladder cancer BJU Int 102 2008 1207 1215
2. Z. Kirkali, T. Chan, and M. Manoharan Bladder cancer: epidemiology, staging and grading, and diagnosis Urology 66 2005 4 34 (Pubitemid 43049607)
3. M. Babjuk, W. Oosterlinck, and R. Sylvester EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update Eur Urol 59 2011 997 1008
4. M.C. Hall, S.S. Chang, and G. Dalbagni Guideline for the management of non muscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update J Urol 178 2007 2314 2330 (Pubitemid 350080987)
5. R.J. Sylvester, A.P. van der Meijden, and W. Oosterlinck Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials Eur Urol 49 2006 466 477 discussion 475-7
6. M.P. Zeegers, F.E. Tan, E. Dorant, and P.A. van Den Brandt The impact of characteristics of cigarette smoking on urinary tract cancer risk: a meta-analysis of epidemiologic studies Cancer 89 2000 630 639 (Pubitemid 30640110)
7. P. Aveyard, P. Adab, K.K. Cheng, D.M. Wallace, K. Hey, and M.F. Murphy Does smoking status influence the prognosis of bladder cancer?. A systematic review BJU Int 90 2002 228 239 (Pubitemid 34989068)
8. C.H. Chen, C.T. Shun, and K.H. Huang Stopping smoking might reduce tumour recurrence in nonmuscle-invasive bladder cancer BJU Int 100 2007 281 286
9. S.A. Strope, and J.E. Montie The causal role of cigarette smoking in bladder cancer initiation and progression, and the role of urologists in smoking cessation J Urol 180 2008 31 37
10. K. Hendricksen, W.P.J. Witjes, and J.G. Idema Comparison of three schedules of intravesical epirubicin in patients with non-muscle-invasive bladder cancer Eur Urol 53 2008 984 991
11. J. Fernandez-Gomez, R. Madero, and E. Solsona Predicting nonmuscle invasive bladder cancer recurrence and progression in patients treated with bacillus Calmette-Guerin: the CUETO scoring model J Urol 182 2009 2195 2203
12. M. Huncharek, R. McGarry, and B. Kupelnick Impact of intravesical chemotherapy on recurrence rate of recurrent superficial transitional cell carcinoma of the bladder: results of a meta-analysis Anticancer Res 21 2001 765 769 (Pubitemid 32267608)
13. N. Fleshner, J. Garland, and A. Moadel Influence of smoking status on the disease-related outcomes of patients with tobacco-associated superficial transitional cell carcinoma of the bladder Cancer 86 1999 2337 2345 (Pubitemid 30010376)
14. M. Kuroda, T. Niijima, T. Kotake, H. Akaza, and S. Hinotsu Effect of prophylactic treatment with intravesical epirubicin on recurrence of superficial bladder cancer - the 6th Trial of the Japanese Urological Cancer Research Group (JUCRG): a randomized trial of intravesical epirubicin at dose of 20 mg/40 ml, 30 mg/40 ml, 40 mg/40 ml Eur Urol 45 2004 600 605 (Pubitemid 38481687)
15. R.J. Sylvester, M.A. Brausi, and W.J. Kirkels Long-term efficacy results of EORTC Genito-Urinary Group randomized phase 3 study 30911 comparing intravesical instillations of epirubicin, bacillus Calmette-Guérin, and bacillus Calmette-Guérin plus isoniazid in patients with intermediate- and high-risk stage Ta T1 urothelial carcinoma of the bladder Eur Urol 57 2010 766 773
16. V. Serretta, C. Pavone, G.B. Ingargiola, G. Daricello, R. Allegro, and M. Pavone-Macaluso TUR and adjuvant intravesical chemotherapy in T1G3 bladder tumors: recurrence, progression and survival in 137 selected patients followed up to 20 years Eur Urol 45 2004 730 736 (Pubitemid 38638392)
17. A.Z. Weizer, C. Tallman, and J.S. Montgomery Long-term outcomes of intravesical therapy for non-muscle invasive bladder cancer World J Urol 29 2011 59 71
18. J. Fernandez-Gomez, E. Solsona, and M. Unda Prognostic factors in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin: multivariate analysis of data from four randomized CUETO trials Eur Urol 53 2008 992 1002 (Pubitemid 351434495)
19. J. Fernandez-Gomez, R. Madero, and E. Solsona The EORTC tables overestimate the risk of recurrence and progression in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guerin: external validation of the EORTC risk tables Eur Urol 60 2011 423 430
20. Y. Hirao, W.J. Kim, and K. Fujimoto Environmental factors promoting bladder cancer Curr Opin Urol 19 2009 494 499
21. Nagelhout GE. Core numbers smoking in the Netherlands [in Dutch]. http://www.stivoro.nl/Upload/artikel/Cijfers/ Kerncijfers%20roken%20in%20Nederland%202009.pdf. Updated 2010.
22. M. Koch, G.B. Hill, and M.S. McPhee Factors affecting recurrence rates in superficial bladder cancer J Natl Cancer Inst 76 1986 1025 1029 (Pubitemid 16093133)
23. A.M. Michalek, K.M. Cummings, and J.E. Pontes Cigarette smoking, tumor recurrence, and survival from bladder cancer Prev Med 14 1985 92 98 (Pubitemid 15037107)
24. J.M. Garcia Mediero, C.J. Angulo, G.M. Lujan, G.N. Rodriguez, and S.A. Berenguer Smoking habit and superficial bladder tumours' natural history [in Spanish] Actas Urol Esp 31 2007 349 354
25. V. Serretta, V. Altieri, and G. Morgia Cigarette smoking and drinking water source: correlation with clinical features and pathology of superficial bladder carcinoma Urol Int 82 2009 318 323
26. C.E. Joshu, A.M. Mondul, and C.L. Meinhold Cigarette smoking and prostate cancer recurrence after prostatectomy J Natl Cancer Inst 103 2011 835 838
27. A.M. Nieder, S. John, C.R. Messina, I.A. Granek, and H.L. Adler Are patients aware of the association between smoking and bladder cancer? J Urol 176 2006 2405 2408 (Pubitemid 44665963)